Organization · Venture Capital
Emmeline Ventures
Emmeline Ventures is a Los Angeles-based venture capital firm that invests in pre-seed and seed-stage tech-enabled startups, focusing on those founded by women or female-identifying individuals. The firm aims to empower women through investments in health, wealth, and environmental safety.
Overview
What Emmeline Ventures does
What Emmeline Ventures is
Emmeline Ventures is a Los Angeles-based venture capital firm that invests in pre-seed and seed-stage tech-enabled startups, focusing on those founded by women or female-identifying individuals. The firm aims to empower women through investments in health, wealth, and environmental safety.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- May 4, 2026
Official channels
Find Emmeline Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Emmeline Ventures as a funder
Investment thesis
Emmeline Ventures invests in female founders building game-changing businesses that empower women to manage their health, build their wealth, and live in a cleaner, safer world.
Focus narrative
Emmeline Ventures primarily invests in pre-seed and seed stage companies led by female founders. The firm emphasizes sectors that address women's health, financial wellness, and sustainability. Their investment thesis targets businesses that tackle critical issues such as maternal health, menstrual health, sexual health, and menopause, with a combined market size projected to reach $100 billion.
Value beyond capital
Emmeline Ventures provides more than just capital; they offer portfolio companies support through pitch deck reviews, capital raising assistance, and operational consulting. The firm is committed to empowering female founders by leveraging their extensive experience and networks to help these businesses thrive.
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- United States · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
Womaness: A wellness brand offering supplements and skincare products tailored for women over 40. Alloy: A digital health platform connecting women with menopause-trained doctors and holistic health solutions. Lōvu Health: A platform focused on improving maternal health outcomes through technology and data. Ema: An AI-powered assistant providing personalized health guidance for women across various life stages. LunaJoy: A digital mental health clinic specializing in women's mental health throughout different life stages. Healthy Pleasure Group: Innovating in the sexual health and technology sector. She Matters: Supporting Black women with culturally competent care and community resources during postpartum experiences. OYA: Developing athletic apparel designed with women's wellness in mind. Flowly: A VR-based solution for managing chronic pain and anxiety.
Common questions
What to know about Emmeline Ventures
Upseed classifies Emmeline Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.